Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 135

1.

Positive correlation between fasting plasma glucagon and serum C-peptide in Japanese patients with diabetes.

Hosokawa Y, Kozawa J, Nishizawa H, Kawamori D, Maeda N, Otsuki M, Matsuoka TA, Iwahashi H, Shimomura I.

Heliyon. 2019 May 13;5(5):e01715. doi: 10.1016/j.heliyon.2019.e01715. eCollection 2019 May.

2.

Circulating osteocalcin as a bone-derived hormone is inversely correlated with body fat in patients with type 1 diabetes.

Takashi Y, Ishizu M, Mori H, Miyashita K, Sakamoto F, Katakami N, Matsuoka TA, Yasuda T, Hashida S, Matsuhisa M, Kuroda A.

PLoS One. 2019 May 3;14(5):e0216416. doi: 10.1371/journal.pone.0216416. eCollection 2019.

3.

Clinical utility of carotid ultrasonography: Application for the management of patients with diabetes.

Katakami N, Matsuoka TA, Shimomura I.

J Diabetes Investig. 2019 Mar 18. doi: 10.1111/jdi.13042. [Epub ahead of print] Review.

4.

Suppression Failure of Cortisol Secretion by Dexamethasone May Occur in Glucagon-like Peptide-1 Receptor Agonist-treated Patients with Diabetic Autonomic Neuropathy.

Nagai Y, Mukai K, Otsuki M, Kimura T, Kozawa J, Nishizawa H, Maeda N, Matsuoka TA, Iwahashi H, Imagawa A, Shimomura I.

Intern Med. 2019 Apr 1;58(7):949-953. doi: 10.2169/internalmedicine.1585-18. Epub 2018 Dec 18.

5.

Evaluation of health utility values for diabetic complications, treatment regimens, glycemic control and other subjective symptoms in diabetic patients using the EQ-5D-5L.

Takahara M, Katakami N, Shiraiwa T, Abe K, Ayame H, Ishimaru Y, Iwamoto M, Shimizu M, Tomonaga O, Yokoyama H, Matsuoka TA, Shimomura I.

Acta Diabetol. 2019 Mar;56(3):309-319. doi: 10.1007/s00592-018-1244-6. Epub 2018 Oct 23.

PMID:
30353354
6.

Different daily glycemic profiles after switching from once-daily alogliptin plus twice-daily metformin to their once-daily fixed-dose combination in Japanese type 2 diabetic patients.

Takahara M, Shiraiwa T, Katakami N, Maeno Y, Yamamoto K, Shiraiwa Y, Yoshida Y, Matsuoka TA, Shimomura I.

Endocr J. 2019 Jan 28;66(1):11-17. doi: 10.1507/endocrj.EJ18-0313. Epub 2018 Oct 11.

7.

Suppression of STAT3 signaling promotes cellular reprogramming into insulin-producing cells induced by defined transcription factors.

Miura M, Miyatsuka T, Katahira T, Sasaki S, Suzuki L, Himuro M, Nishida Y, Fujitani Y, Matsuoka TA, Watada H.

EBioMedicine. 2018 Oct;36:358-366. doi: 10.1016/j.ebiom.2018.09.035. Epub 2018 Sep 25.

8.

Identification of Metabolites Associated with Onset of CAD in Diabetic Patients Using CE-MS Analysis: A Pilot Study.

Omori K, Katakami N, Yamamoto Y, Ninomiya H, Takahara M, Matsuoka TA, Bamba T, Fukusaki E, Shimomura I.

J Atheroscler Thromb. 2019 Mar 1;26(3):233-245. doi: 10.5551/jat.42945. Epub 2018 Aug 1.

9.

Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes.

Ninomiya H, Katakami N, Sato I, Osawa S, Yamamoto Y, Takahara M, Kawamori D, Matsuoka TA, Shimomura I.

J Atheroscler Thromb. 2018 Dec 1;25(12):1274-1284. doi: 10.5551/jat.44859. Epub 2018 Jun 30.

10.

Dysregulated plasma glucagon levels in Japanese young adult type 1 diabetes patients.

Kawamori D, Katakami N, Takahara M, Miyashita K, Sakamoto F, Yasuda T, Matsuoka TA, Shimomura I.

J Diabetes Investig. 2019 Jan;10(1):62-66. doi: 10.1111/jdi.12862. Epub 2018 Jun 7.

11.

Clinical Utility of Carotid Ultrasonography in the Prediction of Cardiovascular Events in Patients with Diabetes: A Combined Analysis of Data Obtained in Five Longitudinal Studies.

Katakami N, Mita T, Gosho M, Takahara M, Irie Y, Yasuda T, Matsuoka TA, Osonoi T, Watada H, Shimomura I.

J Atheroscler Thromb. 2018 Oct 1;25(10):1053-1066. doi: 10.5551/jat.43141. Epub 2018 Feb 14.

12.

Effect of sitagliptin on tissue characteristics of the carotid wall in patients with type 2 diabetes: a post hoc sub-analysis of the sitagliptin preventive study of intima-media thickness evaluation (SPIKE).

Katakami N, Mita T, Irie Y, Takahara M, Matsuoka TA, Gosho M, Watada H, Shimomura I; Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE) Collaborators.

Cardiovasc Diabetol. 2018 Feb 5;17(1):24. doi: 10.1186/s12933-018-0666-3.

13.

Evaluation of the Effect of Alogliptin on Tissue Characteristics of the Carotid Wall: Subanalysis of the SPEAD-A Trial.

Irie Y, Katakami N, Mita T, Takahara M, Matsuoka TA, Gosho M, Watada H, Shimomura I; Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A) Collaborators.

Diabetes Ther. 2018 Feb;9(1):317-329. doi: 10.1007/s13300-018-0367-7. Epub 2018 Jan 12.

14.

Marked recovery from glucotoxicity of β-cell function after medical nutrition therapy without pharmacotherapy in type 2 diabetic outpatients with extreme hyperglycemia: a pilot retrospective study.

Takahara M, Shiraiwa T, Katakami N, Matsuoka TA, Shimomura I.

Endocr J. 2017 Nov 29;64(11):1125-1129. doi: 10.1507/endocrj.EJ17-0222. Epub 2017 Aug 25.

15.

Once-weekly oral antidiabetic agent and treatment satisfaction.

Takahara M, Shiraiwa T, Katakami N, Matsuoka TA, Shimomura I.

Curr Med Res Opin. 2017 Nov;33(11):2093-2094. doi: 10.1080/03007995.2017.1359519. Epub 2017 Aug 16. No abstract available.

PMID:
28737467
16.

Multiple Gouty Tophi with Bone Erosion and Destruction: A Report of an Early-onset Case in an Obese Patient.

D Hayashi R, Yamaoka M, Nishizawa H, Fukuda S, Fujishima Y, Kimura T, Kozawa J, Kita S, Matsuoka TA, Otsuki M, Imagawa A, Ichida K, Taniguchi A, Maeda N, Funahashi T, Shimomura I.

Intern Med. 2017;56(9):1071-1077. doi: 10.2169/internalmedicine.56.7923. Epub 2017 May 1.

17.

Glucotoxicity induces abnormal glucagon secretion through impaired insulin signaling in InR1G cells.

Katsura T, Kawamori D, Aida E, Matsuoka TA, Shimomura I.

PLoS One. 2017 Apr 20;12(4):e0176271. doi: 10.1371/journal.pone.0176271. eCollection 2017.

18.

Patient Perspectives on Combination Therapy of a Once-weekly Oral Medication Plus Daily Medication for Lifestyle-related Chronic Diseases.

Takahara M, Shiraiwa T, Ogawa N, Yamamoto M, Kusuda Y, Shindo M, Hashio S, Katakami N, Matsuoka TA, Shimomura I.

Intern Med. 2017;56(6):615-620. doi: 10.2169/internalmedicine.56.7583. Epub 2017 Mar 17.

19.

Mafa Enables Pdx1 to Effectively Convert Pancreatic Islet Progenitors and Committed Islet α-Cells Into β-Cells In Vivo.

Matsuoka TA, Kawashima S, Miyatsuka T, Sasaki S, Shimo N, Katakami N, Kawamori D, Takebe S, Herrera PL, Kaneto H, Stein R, Shimomura I.

Diabetes. 2017 May;66(5):1293-1300. doi: 10.2337/db16-0887. Epub 2017 Feb 21.

20.

Association between poor psychosocial conditions and diabetic nephropathy in Japanese type 2 diabetes patients: A cross-sectional study.

Ninomiya H, Katakami N, Matsuoka TA, Takahara M, Nishizawa H, Maeda N, Otsuki M, Imagawa A, Iso H, Ohira T, Shimomura I.

J Diabetes Investig. 2018 Jan;9(1):162-172. doi: 10.1111/jdi.12641. Epub 2017 Mar 22.

Supplemental Content

Loading ...
Support Center